User:Genoplan/sandbox/Genoplan

Genoplan Inc. is a global personal genomics and biotechnology company based in Delaware. It is first founded in 2014 and regional headquarters are located in Japan, Singapore, and South Korea.

History
2014: Launched personal genomics services


 * Established Genoplan Korea Inc.
 * 2014 Global K-Startup top prize, Qualcomm/Google prize, Yozma Group prize
 * U.S. East Meet West Startup Competition, 1st prize

2015~2016: Expanded business throughout the world


 * Established US Genoplan Inc.
 * Genoplan Korea Inc. certified as corporate research institute by Korea Industrial Technology Association
 * Genoplan Korea Inc. is registered as genetic testing facility by KCDC
 * Established Genoplan Japan Inc.
 * Series A investment
 * Selected for Creative Challenge SW R&D Support Project by Ministry of Science, ICT and Future Planning
 * Selected as one of the 300 K-Global companies by Ministry of Science, ICT and Future Planning in 2015
 * Certified as venture business by Ministry of SMEs and Startups (~2020)
 * Launched health&beauty service [Genoplan Fit]

2017: Expanded personal genomics services for minorities


 * Established Asia's first automated genetic analysis system
 * Developed genetic analysis technique [DPMO]
 * Launched sports service [Fitness]
 * Launched well-being&beauty service [Wellness]
 * Launched disease prediction services [Cancer], [Cancer+General Diseases]
 * Launched baby service [Kids]

2018: Established business basis through investments


 * Series B investment
 * Relocated Genoplan Korea Inc. headquarters
 * Acquired microarray genotyping instrument to improve genetic testing services

2019~2020: Advanced into global market


 * Established Genoplan Singapore Pte Inc.
 * Expanded Genoplan Japan Inc. Tokyo headquarter offices
 * Advanced into Dubai, Australia, Taiwan market
 * Selected for Corporate Growth Technology Development Support Project by Ministry of Science, ICT and Future Planning
 * Launched [Genoplan], genetic predisposition services for cancer, general diseases, and traits
 * ISO 9001 certified
 * ISO 27001 certified
 * Launched Novel Coronavirus (COVID-19) PCR Test

Location
[Headquarters] 2140 S Dupont Highway, Camden, DE 19934, USA

[Genoplan Japan] (Fukuoka) #221 Fias, 4-1 Kyudai Shinmachi, Nishi-Ku, Fukuoka, Japan (Tokyo) Level 8, 7-7-7 Roppongi, Minato-ku, Tokyo, Japan

[Genoplan Singapore] 438 Alexandra Road, #17-02/03 Alexandra Point, 119958, Singapore

[Genoplan Korea] 21F Kyobo Tower B-dong, Gangnam-daero, Seocho 4-dong, Seocho-gu, Seoul, 06611, South Korea

Products and Services
Genoplan incorporates data science, IT, and biotechnology to its products and services. Based on the genotyping services, Genoplan provides personal genetic testing, optimized healthcare services for its partner companies, and academic research services using microarray genotyping.

Products include Genoplan Genetic Analysis Service and Novel Coronavirus (COVID-19) PCR Test.

Genoplan Genetic Analysis Service

DNA is extracted from saliva samples, then analyzed under the microarray chip that screens more than 700,000 genetic variants. 500 genetic reports are provided based on the analysis results. Customers can organize their future health care plans from their genetic predisposition toward various conditions.

To use Genoplan's genetic analysis services, customers can request online for a test. Saliva collection kit will be delivered to the customer's address. Customers are then required to collect their saliva sample into the collection device and return the kit back to Genoplan laboratory. Test results are issued within 10 business days upon sample reception and can be accessed online via Genoplan website (genoplan.com) or mobile app.

Novel Coronavirus (COVID-19) PCR Test

Novel Coronavirus (COVID-19) PCR Test extracts viral RNA from saliva specimens to detect for specific sequences of the SARS-CoV-2. This test is open to public and does not require a consultation with healthcare professionals.

To use the service, customers can request online for a test. Collection kit will be delivered to the customer's address. Customers are then required to collect their saliva specimens into the collection device and return the kit back to Genoplan laboratory. Test results are issued within 72 hours upon specimen reception and can be accessed online via Genoplan website (genoplan.com) or mobile app.